Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2034

Annual patent cliff calendar for 2034 — US pharmaceutical patents by expiration date.

Patents
1,452

Quick answer

1,452 indexed pharmaceutical patents have expiration dates in 2034. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8784791

    Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester

    Nektar Therapeutics · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8785661

    Oligome-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8785407

    Antisense antiviral agent and method for treating ssRNA viral infection

    Sarepta Therapeutics, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8785377

    Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8784870

    Controlled release compositions for modulating free-radical induced damage and methods of use thereof

    The Regents of the University of California · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8785191

    Concentration of stem cells obtained during orthopaedic surgeries

    UNIVERSITY OF CONNECTICUT · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8785393

    Ophthalmic pharmaceutical compositions of DP2 receptor antagonists

    Panmira Pharmaceuticals, LLC · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8785414

    Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8785444

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8785476

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8785487

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8785492

    Treatment of circadian rhythm disorders

    VANDA PHARMACEUTICALS INC. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8785633

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8785450

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8785640

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8784780

    High oil-content emollient aerosol foam compositions

    Precision Dermatology, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8785373

    Agents capable of downregulating an MSF-A-dependent HIF-1alpha and use thereof in cancer treatment

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8784885

    Controlled release preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8785168

    Formulations for lysosomal enzymes

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8784895

    Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same

    Northwestern University · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8784881

    Liposomal curcumin for treatment of diseases

    The Board of Regents of the University of Texas System · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8784866

    Water-soluble carbon nanotube compositions for drug delivery and medicinal applications

    The Board of Regents of the University of Texas System · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8784817

    Method for killing IL-1 alpha expressing cells

    XBIOTECH INC. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8784802

    Ischemic tissue cell therapy

    Cryopraxis Criobiologia Ltda. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8784849

    Hydroxyapatite-targeting poly(ethylene glycol) and related polymers

    Nektar Therapeutics · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8785601

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8785499

    Targeting NAD biosynthesis in bacterial pathogens

    The Board of Regents of the University of Texas System · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8785514

    Dual-cure dental resins and adhesives with increased cure and color stability and low color

    The Board of Regents of the University of Texas System · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8785491

    Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8785505

    Toxicology and cellular effect of manufactured nanomaterials

    The Regents of the University of California · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8785483

    Methods for treating COPD

    The Board of Regents of the University of Texas System · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8785486

    Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8785460

    Tricyclic compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8785449

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8785442

    Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof

    Curegenix, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8785429

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8785609

    Cloning and expression of HTLV-III DNA

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8785421

    Use of vitamin D in dairy mastitis treatment

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8785437

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8785410

    Antisense composition and method for treating muscle atrophy

    Sarepta Therapeutics, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8785409

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 2014206764

    Poly(Nitrogen/Amine) Derivatives of a Natural Wax and Ophthalmic Compositions

    BAUSCH & LOMB [US] · Granted Thu Jul 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jul 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8791062

    Skin permeating and cell entering (SPACE) peptides and methods of use thereof

    The Regents of the University of California · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8790878

    Diagnosis and treatment of breast cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8790639

    Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8790641

    Production of high mannose proteins in plant culture and therapeutic uses thereof

    Protalix Ltd. · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8790652

    Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis

    VACCINEX, INC. · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8790655

    Conjugates of synthetic TLR agonists and uses therefor

    The Regents of the University of California · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2034?

1,452 published patents in our USPTO index have expiration dates falling in calendar year 2034.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.